The global Veterinary Regenerative Medicine market size is projected to grow from US$ 260.3 million in 2022 to US$ 615.4 million in 2029; it is expected to grow at a CAGR of 13.1% from 2023 to 2029.
Regenerative medicine therapy has grown in popularity in both human and veterinary medicine for the treatment of a variety of disease conditions. In the rapidly developing field of veterinary regenerative medicine, cells, and tissues-such as live cells, serum, or bone-are utilized in animals with the hopes of restoring diseased or damaged tissues or organs. Recent studies have shown that it is effective in controlling a variety of orthopedic disorders in companion animals, including osteoarthritis and soft tissue injuries. Regenerative medicine is increasingly used as an alternative to surgical, medicinal, and rehabilitation therapy or as a multimodal approach to treating a condition or injury.
Regenerative medicine aims to restore the normal function of diseased or damaged cells, tissues, and organs using a set of different approaches, including cell-based therapies. In the veterinary field, regenerative medicine is strongly related to the use of mesenchymal stromal cells (MSCs), which belong to the body repair system and are defined as multipotent progenitor cells, able to self-replicate and to differentiate into different cell types.
LPI (LP Information)' newest research report, the “Veterinary Regenerative Medicine Industry Forecast” looks at past sales and reviews total world Veterinary Regenerative Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Veterinary Regenerative Medicine sales for 2023 through 2029. With Veterinary Regenerative Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Regenerative Medicine industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Regenerative Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Regenerative Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Veterinary Regenerative Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Regenerative Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Regenerative Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Regenerative Medicine market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Platelet-Rich Plasma (PRP)
Stem Cell Therapy
Others
Segmentation by application
Veterinary Hospitals/Clinics
Veterinary Research Institutes
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
ACell Inc. (Integra LifeSciences)
Animal Cell Therapies, Inc.
Ardent
Boehringer Ingelheim International GmbH
Cell Therapy Sciences
Dechra
Enso Discoveries
South Paws Veterinary Surgical Specialists
Veterinary Specialty Center
Vetbiologics
Vetherapy
VetStem, Inc.
Zoetis

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Veterinary Regenerative Medicine Market Size 2018-2029 2.1.2 Veterinary Regenerative Medicine Market Size CAGR by Region 2018 VS 2022 VS 2029 2.2 Veterinary Regenerative Medicine Segment by Type 2.2.1 Platelet-Rich Plasma (PRP) 2.2.2 Stem Cell Therapy 2.2.3 Others 2.3 Veterinary Regenerative Medicine Market Size by Type 2.3.1 Veterinary Regenerative Medicine Market Size CAGR by Type (2018 VS 2022 VS 2029) 2.3.2 Global Veterinary Regenerative Medicine Market Size Market Share by Type (2018-2023) 2.4 Veterinary Regenerative Medicine Segment by Application 2.4.1 Veterinary Hospitals/Clinics 2.4.2 Veterinary Research Institutes 2.5 Veterinary Regenerative Medicine Market Size by Application 2.5.1 Veterinary Regenerative Medicine Market Size CAGR by Application (2018 VS 2022 VS 2029) 2.5.2 Global Veterinary Regenerative Medicine Market Size Market Share by Application (2018-2023) 3 Veterinary Regenerative Medicine Market Size by Player 3.1 Veterinary Regenerative Medicine Market Size Market Share by Players 3.1.1 Global Veterinary Regenerative Medicine Revenue by Players (2018-2023) 3.1.2 Global Veterinary Regenerative Medicine Revenue Market Share by Players (2018-2023) 3.2 Global Veterinary Regenerative Medicine Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Veterinary Regenerative Medicine by Regions 4.1 Veterinary Regenerative Medicine Market Size by Regions (2018-2023) 4.2 Americas Veterinary Regenerative Medicine Market Size Growth (2018-2023) 4.3 APAC Veterinary Regenerative Medicine Market Size Growth (2018-2023) 4.4 Europe Veterinary Regenerative Medicine Market Size Growth (2018-2023) 4.5 Middle East & Africa Veterinary Regenerative Medicine Market Size Growth (2018-2023) 5 Americas 5.1 Americas Veterinary Regenerative Medicine Market Size by Country (2018-2023) 5.2 Americas Veterinary Regenerative Medicine Market Size by Type (2018-2023) 5.3 Americas Veterinary Regenerative Medicine Market Size by Application (2018-2023) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Veterinary Regenerative Medicine Market Size by Region (2018-2023) 6.2 APAC Veterinary Regenerative Medicine Market Size by Type (2018-2023) 6.3 APAC Veterinary Regenerative Medicine Market Size by Application (2018-2023) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Veterinary Regenerative Medicine by Country (2018-2023) 7.2 Europe Veterinary Regenerative Medicine Market Size by Type (2018-2023) 7.3 Europe Veterinary Regenerative Medicine Market Size by Application (2018-2023) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Veterinary Regenerative Medicine by Region (2018-2023) 8.2 Middle East & Africa Veterinary Regenerative Medicine Market Size by Type (2018-2023) 8.3 Middle East & Africa Veterinary Regenerative Medicine Market Size by Application (2018-2023) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Veterinary Regenerative Medicine Market Forecast 10.1 Global Veterinary Regenerative Medicine Forecast by Regions (2024-2029) 10.1.1 Global Veterinary Regenerative Medicine Forecast by Regions (2024-2029) 10.1.2 Americas Veterinary Regenerative Medicine Forecast 10.1.3 APAC Veterinary Regenerative Medicine Forecast 10.1.4 Europe Veterinary Regenerative Medicine Forecast 10.1.5 Middle East & Africa Veterinary Regenerative Medicine Forecast 10.2 Americas Veterinary Regenerative Medicine Forecast by Country (2024-2029) 10.2.1 United States Veterinary Regenerative Medicine Market Forecast 10.2.2 Canada Veterinary Regenerative Medicine Market Forecast 10.2.3 Mexico Veterinary Regenerative Medicine Market Forecast 10.2.4 Brazil Veterinary Regenerative Medicine Market Forecast 10.3 APAC Veterinary Regenerative Medicine Forecast by Region (2024-2029) 10.3.1 China Veterinary Regenerative Medicine Market Forecast 10.3.2 Japan Veterinary Regenerative Medicine Market Forecast 10.3.3 Korea Veterinary Regenerative Medicine Market Forecast 10.3.4 Southeast Asia Veterinary Regenerative Medicine Market Forecast 10.3.5 India Veterinary Regenerative Medicine Market Forecast 10.3.6 Australia Veterinary Regenerative Medicine Market Forecast 10.4 Europe Veterinary Regenerative Medicine Forecast by Country (2024-2029) 10.4.1 Germany Veterinary Regenerative Medicine Market Forecast 10.4.2 France Veterinary Regenerative Medicine Market Forecast 10.4.3 UK Veterinary Regenerative Medicine Market Forecast 10.4.4 Italy Veterinary Regenerative Medicine Market Forecast 10.4.5 Russia Veterinary Regenerative Medicine Market Forecast 10.5 Middle East & Africa Veterinary Regenerative Medicine Forecast by Region (2024-2029) 10.5.1 Egypt Veterinary Regenerative Medicine Market Forecast 10.5.2 South Africa Veterinary Regenerative Medicine Market Forecast 10.5.3 Israel Veterinary Regenerative Medicine Market Forecast 10.5.4 Turkey Veterinary Regenerative Medicine Market Forecast 10.5.5 GCC Countries Veterinary Regenerative Medicine Market Forecast 10.6 Global Veterinary Regenerative Medicine Forecast by Type (2024-2029) 10.7 Global Veterinary Regenerative Medicine Forecast by Application (2024-2029) 11 Key Players Analysis 11.1 ACell Inc. (Integra LifeSciences) 11.1.1 ACell Inc. (Integra LifeSciences) Company Information 11.1.2 ACell Inc. (Integra LifeSciences) Veterinary Regenerative Medicine Product Offered 11.1.3 ACell Inc. (Integra LifeSciences) Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) 11.1.4 ACell Inc. (Integra LifeSciences) Main Business Overview 11.1.5 ACell Inc. (Integra LifeSciences) Latest Developments 11.2 Animal Cell Therapies, Inc. 11.2.1 Animal Cell Therapies, Inc. Company Information 11.2.2 Animal Cell Therapies, Inc. Veterinary Regenerative Medicine Product Offered 11.2.3 Animal Cell Therapies, Inc. Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) 11.2.4 Animal Cell Therapies, Inc. Main Business Overview 11.2.5 Animal Cell Therapies, Inc. Latest Developments 11.3 Ardent 11.3.1 Ardent Company Information 11.3.2 Ardent Veterinary Regenerative Medicine Product Offered 11.3.3 Ardent Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) 11.3.4 Ardent Main Business Overview 11.3.5 Ardent Latest Developments 11.4 Boehringer Ingelheim International GmbH 11.4.1 Boehringer Ingelheim International GmbH Company Information 11.4.2 Boehringer Ingelheim International GmbH Veterinary Regenerative Medicine Product Offered 11.4.3 Boehringer Ingelheim International GmbH Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) 11.4.4 Boehringer Ingelheim International GmbH Main Business Overview 11.4.5 Boehringer Ingelheim International GmbH Latest Developments 11.5 Cell Therapy Sciences 11.5.1 Cell Therapy Sciences Company Information 11.5.2 Cell Therapy Sciences Veterinary Regenerative Medicine Product Offered 11.5.3 Cell Therapy Sciences Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) 11.5.4 Cell Therapy Sciences Main Business Overview 11.5.5 Cell Therapy Sciences Latest Developments 11.6 Dechra 11.6.1 Dechra Company Information 11.6.2 Dechra Veterinary Regenerative Medicine Product Offered 11.6.3 Dechra Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) 11.6.4 Dechra Main Business Overview 11.6.5 Dechra Latest Developments 11.7 Enso Discoveries 11.7.1 Enso Discoveries Company Information 11.7.2 Enso Discoveries Veterinary Regenerative Medicine Product Offered 11.7.3 Enso Discoveries Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) 11.7.4 Enso Discoveries Main Business Overview 11.7.5 Enso Discoveries Latest Developments 11.8 South Paws Veterinary Surgical Specialists 11.8.1 South Paws Veterinary Surgical Specialists Company Information 11.8.2 South Paws Veterinary Surgical Specialists Veterinary Regenerative Medicine Product Offered 11.8.3 South Paws Veterinary Surgical Specialists Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) 11.8.4 South Paws Veterinary Surgical Specialists Main Business Overview 11.8.5 South Paws Veterinary Surgical Specialists Latest Developments 11.9 Veterinary Specialty Center 11.9.1 Veterinary Specialty Center Company Information 11.9.2 Veterinary Specialty Center Veterinary Regenerative Medicine Product Offered 11.9.3 Veterinary Specialty Center Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) 11.9.4 Veterinary Specialty Center Main Business Overview 11.9.5 Veterinary Specialty Center Latest Developments 11.10 Vetbiologics 11.10.1 Vetbiologics Company Information 11.10.2 Vetbiologics Veterinary Regenerative Medicine Product Offered 11.10.3 Vetbiologics Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) 11.10.4 Vetbiologics Main Business Overview 11.10.5 Vetbiologics Latest Developments 11.11 Vetherapy 11.11.1 Vetherapy Company Information 11.11.2 Vetherapy Veterinary Regenerative Medicine Product Offered 11.11.3 Vetherapy Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) 11.11.4 Vetherapy Main Business Overview 11.11.5 Vetherapy Latest Developments 11.12 VetStem, Inc. 11.12.1 VetStem, Inc. Company Information 11.12.2 VetStem, Inc. Veterinary Regenerative Medicine Product Offered 11.12.3 VetStem, Inc. Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) 11.12.4 VetStem, Inc. Main Business Overview 11.12.5 VetStem, Inc. Latest Developments 11.13 Zoetis 11.13.1 Zoetis Company Information 11.13.2 Zoetis Veterinary Regenerative Medicine Product Offered 11.13.3 Zoetis Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023) 11.13.4 Zoetis Main Business Overview 11.13.5 Zoetis Latest Developments 12 Research Findings and Conclusion